Skip to content

Prismatic Correction for Improving Near Visual Acuity in Patients With Maculopathy

Prismatic Correction for Improving Near Visual Acuity in Patients With Maculopathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05747417
Enrollment
100
Registered
2023-02-28
Start date
2022-06-01
Completion date
2022-12-31
Last updated
2023-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Acuity

Brief summary

patients with maculopathy reported in low vision clinic are tested for prismatic glasses for near vision. The pre and post visual acuity was recorded.

Detailed description

Diagnosed patient of maculopathy who was visited in low vision clinic are divided in two groups , one is control group (prescribed simple near vision glasses) and other is interventional group(prescribed prismatic glasses). Both groups were follow up after one month to check the improvement in near visual acuity

Interventions

OTHERprismatic glasses

prism glasses ranging from 4-10 prism diopters

Sponsors

Al-Shifa Trust Eye Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Diagnosed patients of maculopathy refer to low vision clinic 2. Patients with both genders 3. VA from LogMAR 1.0 to LogMAR 0.3

Exclusion criteria

1. Maculopathy patients with other ocular disease 2. VA worsen the LogMAR 1.0 3. Patients with mental illness and other physical lmitations

Design outcomes

Primary

MeasureTime frameDescription
Prismatic Correction for Improving Near Visual Acuity in Patients with Maculopathy7 -8 monthsA Per forma/questionnaire is used to document Near visual Acuity with the help of light house Chart to see improvement in visual acuity

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026